Ignite Creation Date:
2025-12-24 @ 10:16 PM
Ignite Modification Date:
2025-12-29 @ 9:24 PM
Study NCT ID:
NCT01409135
Status:
COMPLETED
Last Update Posted:
2024-03-12
First Post:
2011-07-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07-11
Start Date Type:
ACTUAL
Primary Completion Date:
2015-04-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-04-27
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-29
First Submit QC Date:
None
Study First Post Date:
2011-08-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-11
Last Update Post Date:
2024-03-12
Last Update Post Date Type:
ACTUAL